AMAG Pharmaceuticals EV/EBIT
Was ist das EV/EBIT von AMAG Pharmaceuticals?
EV/EBIT von AMAG Pharmaceuticals, Inc. ist N/A
Was ist die Definition von EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu AMAG Pharmaceuticals
Was macht AMAG Pharmaceuticals?
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
Unternehmen mit ev/ebit ähnlich AMAG Pharmaceuticals
- SPORTTOTAL AG hat EV/EBIT von N/A
- Christopher & Banks hat EV/EBIT von N/A
- MoSys hat EV/EBIT von N/A
- The Victoria Mills hat EV/EBIT von N/A
- Lonestar Resources US Inc hat EV/EBIT von N/A
- Gold'n Futures Mineral hat EV/EBIT von N/A
- AMAG Pharmaceuticals hat EV/EBIT von N/A
- Conart Engineers hat EV/EBIT von N/A
- Asia-Pac Investment hat EV/EBIT von N/A
- St. James Gold hat EV/EBIT von N/A
- Anika Therapeutics hat EV/EBIT von N/A
- Dyadic International hat EV/EBIT von N/A
- UTStarcom Corp hat EV/EBIT von N/A